{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:51:35Z","timestamp":1783014695397,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL135103"],"award-info":[{"award-number":["R01 HL135103"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship #829952"],"award-info":[{"award-number":["Postdoctoral Fellowship #829952"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Positron emission tomography (PET)\/computed tomography (CT) imaging with fluorine-18 (<jats:sup>18<\/jats:sup>F)-sodium fluoride (NaF) provides assessment of active vascular microcalcification, but its utility for evaluating diabetes mellitus (DM)- and chronic kidney disease (CKD)-induced atherosclerosis in peripheral arterial disease (PAD) has not been comprehensively evaluated. This study sought to use <jats:sup>18<\/jats:sup>F-NaF PET\/CT to quantify and compare active microcalcification on an artery-by-artery basis in healthy subjects, PAD patients with or without DM, and PAD patients with or without CKD. Additionally, we evaluated the contributions of DM, CKD, statin use and established CT-detectable calcium to <jats:sup>18<\/jats:sup>F-NaF uptake for each lower extremity artery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PAD patients (<jats:italic>n<\/jats:italic>\u2009=\u200948) and healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u20098) underwent lower extremity <jats:sup>18<\/jats:sup>F-NaF PET\/CT imaging. Fused PET\/CT images guided segmentation of arteries of interest (i.e., femoral-popliteal, anterior tibial, tibioperoneal trunk, posterior tibial, and peroneal) and quantification of <jats:sup>18<\/jats:sup>F-NaF uptake. <jats:sup>18<\/jats:sup>F-NaF uptake was assessed for each artery and compared between subject groups. Additionally, established calcium burden was quantified for each artery using CT calcium mass score. Univariate and multivariate analyses were performed to evaluate DM, CKD, statin use, and CT calcium mass as predictors of <jats:sup>18<\/jats:sup>F-NaF uptake in PAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PAD patients with DM or CKD demonstrated significantly higher active microcalcification (i.e., <jats:sup>18<\/jats:sup>F-NaF uptake) for all arteries when compared to PAD patients without DM or CKD. Univariate and multivariate analyses revealed that concomitant DM or CKD was associated with increased microcalcification for all arteries of interest and this increased disease risk remained significant after adjusting for patient age, sex, and body mass index. Statin use was only associated with decreased microcalcification for the femoral-popliteal artery in multivariate analyses. Established CT-detectable calcium was not significantly associated with <jats:sup>18<\/jats:sup>F-NaF uptake for 4 out of 5 arteries of interest.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:sup>18<\/jats:sup>F-NaF PET\/CT imaging quantifies vessel-specific active microcalcification in PAD that is increased in multiple lower extremity arteries by DM and CKD and decreased in the femoral-popliteal artery by statin use. <jats:sup>18<\/jats:sup>F-NaF PET imaging is complementary to and largely independent of established CT-detectable arterial calcification. <jats:sup>18<\/jats:sup>F-NaF PET\/CT imaging may provide an approach for non-invasively quantifying vessel-specific responses to emerging anti-atherogenic therapies or CKD treatment in patients with PAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-023-00951-0","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:03:36Z","timestamp":1673971416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vessel-by-vessel analysis of lower extremity 18F-NaF PET\/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Ting-Heng","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor T.","family":"Rimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surina","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly K.","family":"Wynveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan N.","family":"Eisert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumudha Narayana","family":"Musini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Janse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Bobbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur P.","family":"Sarac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A.","family":"Atway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-1011","authenticated-orcid":false,"given":"Mitchel R.","family":"Stacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"951_CR1","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144:e171\u201391.","journal-title":"Circulation"},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","volume":"286","author":"AT Hirsch","year":"2001","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317\u201324.","journal-title":"JAMA"},{"key":"951_CR3","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","volume":"40","author":"JA Barnes","year":"2020","unstructured":"Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arter Thromb Vasc Biol. 2020;40:1808\u201317.","journal-title":"Arter Thromb Vasc Biol."},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1358863X08089277","volume":"13","author":"AT Hirsch","year":"2008","unstructured":"Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209\u201315.","journal-title":"Vasc Med"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.avsg.2010.03.015","volume":"24","author":"MR Jaff","year":"2010","unstructured":"Jaff MR, Cahill KE, Yu AP, Birnbaum HG, Engelhart LM. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease. Ann Vasc Surg. 2010;24:577\u201387.","journal-title":"Ann Vasc Surg"},{"key":"951_CR6","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2337\/dc09-0459","volume":"32","author":"ES Huang","year":"2009","unstructured":"Huang ES, Basu A, O\u2019Grady M, Capretta JC. Projecting the future diabetes popluation size and related costs for the US. Diabetes Care. 2009;32:2225\u20139.","journal-title":"Diabetes Care."},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/bmj.293.6555.1137","volume":"293","author":"R Jelnes","year":"1986","unstructured":"Jelnes R, Gaardsting O, Jensen KH, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed). 1986;293:1137\u201340.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"951_CR8","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","volume":"94","author":"JI Weitz","year":"1996","unstructured":"Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026\u201349.","journal-title":"Circulation"},{"key":"951_CR9","first-page":"50","volume":"30","author":"J Dormandy","year":"1989","unstructured":"Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg. 1989;30:50\u20137.","journal-title":"J Cardiovasc Surg"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg. 2007;45:S5-67.","journal-title":"J Vasc Surg"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/VHRM.S209241","volume":"15","author":"S Duff","year":"2019","unstructured":"Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Heal Risk Manag. 2019;15:187\u2013208.","journal-title":"Vasc Heal Risk Manag"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570\u201381.","journal-title":"JAMA"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","volume":"24","author":"EB Jude","year":"2001","unstructured":"Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433\u20137.","journal-title":"Diabetes Care"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jvs.2020.08.032","volume":"73","author":"M Anantha-Narayanan","year":"2021","unstructured":"Anantha-Narayanan M, Sheikh AB, Nagpal S, Jelani Q-A, Smolderen KG, Regan C, et al. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease. J Vasc Surg. 2021;73:331\u201340.","journal-title":"J Vasc Surg"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/path.5334","volume":"249","author":"Z Li","year":"2019","unstructured":"Li Z, Wu J, Zhang X, Ou C, Zhong Z, Chen Y, et al. CDC42 promotes vascular calcification in chronic kidney disease. J Pathol. 2019;249:461\u201371.","journal-title":"J Pathol"},{"key":"951_CR16","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","volume":"83","author":"KJ Rocha-Singh","year":"2014","unstructured":"Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212\u201320.","journal-title":"Catheter Cardiovasc Interv"},{"key":"951_CR17","first-page":"200","volume":"20","author":"M Haltmayer","year":"2001","unstructured":"Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20:200\u20137.","journal-title":"Int Angiol"},{"key":"951_CR18","doi-asserted-by":"publisher","first-page":"e90201","DOI":"10.1371\/journal.pone.0090201","volume":"9","author":"C-L Huang","year":"2014","unstructured":"Huang C-L, Wu I-H, Wu Y-W, Hwang J-J, Wang S-S, Chen W-J, et al. Association of lower extremity arterial calcification with amputation and mortality in patients with symptomatic peripheral artery disease. PLoS ONE. 2014;9:e90201.","journal-title":"PLoS ONE"},{"key":"951_CR19","doi-asserted-by":"publisher","first-page":"e0182952","DOI":"10.1371\/journal.pone.0182952","volume":"12","author":"MM Chowdhury","year":"2017","unstructured":"Chowdhury MM, Makris GC, Tarkin JM, Joshi FR, Hayes PD, Rudd JHF, et al. Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity. PLoS ONE. 2017;12:e0182952.","journal-title":"PLoS ONE"},{"key":"951_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jvs.2010.09.070","volume":"53","author":"T Ohtake","year":"2011","unstructured":"Ohtake T, Oka M, Ikee R, Mochida Y, Ishioka K, Moriya H, et al. Impact of lower limbs\u2019 arterial calcification on the prevalence and severity of PAD in patients on hemodialysis. J Vasc Surg. 2011;53:676\u201383.","journal-title":"J Vasc Surg"},{"key":"951_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.jacc.2007.12.058","volume":"51","author":"RJ Guzman","year":"2008","unstructured":"Guzman RJ, Brinkley DM, Schumacher PM, Donahue RMJ, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51:1967\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"951_CR22","doi-asserted-by":"publisher","first-page":"e001823","DOI":"10.1161\/JAHA.115.001823","volume":"4","author":"KG Smolderen","year":"2015","unstructured":"Smolderen KG, van Zitteren M, Jones PG, Spertus JA, Heyligers JM, Nooren MJ, et al. Long-term prognostic risk in lower extremity peripheral arterial disease as a function of the number of peripheral arterial lesions. J Am Hear Assoc. 2015;4:e001823.","journal-title":"J Am Hear Assoc"},{"key":"951_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","volume":"59","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Chow MWL, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluorid uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539\u201348.","journal-title":"J Am Coll Cardiol."},{"key":"951_CR24","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/ncomms8495","volume":"6","author":"A Irkle","year":"2015","unstructured":"Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JLE, Dweck MR, et al. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495.","journal-title":"Nat Commun"},{"key":"951_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MNM.0b013e32834c187e","volume":"33","author":"Y Li","year":"2012","unstructured":"Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun. 2012;33:14\u201320.","journal-title":"Nucl Med Commun"},{"key":"951_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12410-019-9491-7","volume":"12","author":"MR Stacy","year":"2019","unstructured":"Stacy MR. Radionuclide imaging of atherothrombotic diseases. Curr Cardiovasc Imaging Rep. 2019;12:17.","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"951_CR27","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s12350-020-02099-z","volume":"28","author":"RAP Takx","year":"2021","unstructured":"Takx RAP, van Asperen R, Bartstra JW, Zwakenberg SR, Wolterink JM, Celeng C, et al. Determinants of 18F-NaF uptake in femoral arteries in patients with type 2 diabetes mellitus. J Nucl Cardiol. 2021;28:2700\u20135.","journal-title":"J Nucl Cardiol"},{"key":"951_CR28","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s12350-020-02031-5","volume":"28","author":"AM den Harder","year":"2021","unstructured":"den Harder AM, Wolterink JM, Bartstra JW, Spiering W, Zwakenberg SR, Beulens JW, et al. Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification? J Nucl Cardiol. 2021;28:2244\u201354.","journal-title":"J Nucl Cardiol"},{"key":"951_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/RLU.0000000000003344","volume":"45","author":"SN Eisert","year":"2020","unstructured":"Eisert SN, Chou TH, Bobbey AJ, Go MR, Stacy MR. Noninvasive detection of active microcalcification in an occlusive peripheral vascular aneurysm using 18F-NaF PET\/CT imaging. Clin Nucl Med. 2020;45:1029\u201331.","journal-title":"Clin Nucl Med"},{"key":"951_CR30","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","volume":"69","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69:e71-126.","journal-title":"J Am Coll Cardiol"},{"key":"951_CR31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/heartjnl-2020-318004","volume":"107","author":"JA Lamprea-Montealegre","year":"2021","unstructured":"Lamprea-Montealegre JA, Shlipak MG, Estrella MM. Chronic kidney disease detection, staging, and treatment in cardiovascular disease prevention. Heart. 2021;107:1282\u20138.","journal-title":"Heart"},{"key":"951_CR32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00259-015-3259-3","volume":"43","author":"J Bucerius","year":"2016","unstructured":"Bucerius J, Hyafil F, Verberne HJ, Slart RHJA, Lindner O, Sciagra R, et al. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging. 2016;43:780\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"951_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"951_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2261-13-81","volume":"13","author":"A Teren","year":"2013","unstructured":"Teren A, Beutner F, Wirkner K, Loeffler M, Scholz M. Validity, intra- and inter-observer reliability of automated devices for the assessment of ankle brachial index using photo-plethysmography. BMC Cardiovasc Disord. 2013;13:81.","journal-title":"BMC Cardiovasc Disord"},{"key":"951_CR35","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1161\/ATVBAHA.120.313785","volume":"40","author":"E Tzolos","year":"2020","unstructured":"Tzolos E, Dweck MR. 18F-sodium fluoride (18F-NaF) for imaging microcalcification activity in the cardiovascular system. Arter Thromb Vasc Biol. 2020;40:1620\u20136.","journal-title":"Arter Thromb Vasc Biol"},{"key":"951_CR36","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.2147\/IJGM.S322417","volume":"14","author":"R Serra","year":"2021","unstructured":"Serra R, Bracale UM, Ielapi N, Del Guercio L, Di Taranto MD, Sodo M, et al. The impact of chronic kidney disease on peripheral artery disease and peripheral revascularization. Int J Gen Med. 2021;14:3749\u201359.","journal-title":"Int J Gen Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-023-00951-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:05:48Z","timestamp":1673971548000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-023-00951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s13550-023-00951-0","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study protocol was approved by the Nationwide Children\u2019s Hospital IRB as well as the Radiation Safety Committee. No animals were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}